Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears debate on requiring pharmacy‑benefit pathway for injectable PrEP
Summary
SB 1023 would require insurers that cover long‑acting injectable PrEP under medical benefits to also cover it under pharmacy benefits to ease clinic access; advocates said current billing blocks rollout while health plans warned the bill intrudes on benefit design and could create administrative burdens.
On behalf of Sen. Laird, the committee heard SB 1023 to make insurers that cover long‑acting injectable PrEP through a medical benefit also provide a pharmacy‑benefit pathway to support timely administration. Jonathan Froxweig, director of health justice policy at the San Francisco AIDS Foundation, said the state’s progress against new HIV infections has stalled and that insurer billing practices are creating…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
